BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/6/2015 9:08:00 AM | Browse: 1110 | Download: 1467
Publication Name World Journal of Gastroenterology
Manuscript ID 10007
Country China
Received
2014-03-08 10:16
Peer-Review Started
2014-03-08 10:28
To Make the First Decision
2014-04-24 10:35
Return for Revision
2014-06-12 09:29
Revised
2014-09-15 15:47
Second Decision
2014-10-21 17:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-10-21 17:56
Articles in Press
2014-10-21 18:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-10-31 09:43
Typeset the Manuscript
2014-12-17 11:16
Publish the Manuscript Online
2015-01-06 09:08
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Efficacy of docetaxel combined with oxaliplatin and fluorouracil against stage Ⅲ/Ⅳ gastric cancer
Manuscript Source Unsolicited Manuscript
All Author List Yao-Jun Yu, Wei-Jian Sun, Ming-Dong Lu, Fei-Hai Wang, Dan-Si Qi, Yi Zhang, Pi-Hong Li, He Huang, Tao You and Zhi-Qiang Zheng
Funding Agency and Grant Number
Corresponding Author Yao-Jun Yu, MD, NO H09 Disease Dist., Department of General Surgery, the Second Affiliated Hospital of Wenzhou Medical University, No. 109, Xueyuan Road, Wenzhou 325003, Zhejiang Province, China. yuyaojun26@163.com
Key Words Gastric cancer; Neoadjuvant chemotherapy; Docetaxel; Oxaliplatin
Core Tip This study analysed the combination of docetaxel, oxaliplatin and fluorouracil in the neoadjuvant chemotherapy towards stage Ⅲ/Ⅳ gastric cancer patients, and observed the changes of tumours after chemotherapy, as well as the surgical resection rate, postoperative pathological remission degree, clinical symptom remission degree and adverse reactions, aiming to verify the effectiveness and safety of this regimen in clinical applications.
Publish Date 2015-01-06 09:08
Citation Yu YJ, Sun WJ, Lu MD, Wang FH, Qi DS, Zhang Y, Li PH, Huang H, You T, Zheng ZQ. Efficacy of docetaxel combined with oxaliplatin and fluorouracil against stage Ⅲ/Ⅳ gastric cancer. World J Gastroenterol 2014; 20(48): 18413-18419
URL http://www.wjgnet.com/1007-9327/full/v20/i48/18413.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i48.18413
Full Article (PDF) WJG-20-18413.pdf
Full Article (Word) WJG-20-18413.doc
Manuscript File 10007-Review.doc
Answering Reviewers 10007-Answering reviewers.pdf
Copyright License Agreement 10007-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 10007-Language certificate.pdf
Peer-review Report 10007-Peer review(s).pdf
Scientific Misconduct Check 10007-CrossCheck.jpg
Scientific Editor Work List 10007-Scientific editor work list.pdf